Capital Squared Financial’s Merck MRK Stock Holding History

Capital Squared Financial’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$253K	Buy	+1,739	New	+$240K	0.16%	76

Other funds holding MRK

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $24.1B AUM 30.72% 1-Year Est. Return

Capital Squared Financial's MRK Position: Q3 2026 in Review

Capital Squared Financial opened a new position in Merck (MRK) in Q3 2026: 1,739 shares worth $253K. The stake represents 0.16% of the portfolio and ranks #76 among its holdings.

1,812 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

Capital Squared Financial held 1,739 shares of Merck worth $253K as of Q3 2026.
Merck was a new Capital Squared Financial position in Q3 2026.
Merck made up 0.16% of Capital Squared Financial's portfolio in Q3 2026, its #76 holding.
1,812 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Capital Squared Financial's 13F filing for Q3 2026, filed 30 Oct 2026.